Systematic screening of gender violence and domestic violence among HIV-positive patients: the VIHOLETA study.
Por:
Llenas-García J, Masiá M, Pascual Perez R, González-Cuello I, Agulló Re V, Romero Nieto M, Amat Díaz M, Padilla Urrea S, Rodríguez Lucena FJ and Wikman-Jorgensen P
Publicada:
1 oct 2023
Ahead of Print:
28 sep 2022
Resumen:
We conducted a multicentre observational study in people living with HIV (PLHIV) on antiretroviral therapy in Alicante (Spain) from 2019 to 2020 aiming to analyse the prevalence of abuse and assess treatment adherence according to this variable. We used the Abuse Assessment Screen tool, the simplified medication adherence questionnaire and the medication possession ratio to assess outcomes.. Of the 161 included PLHIV, 53 (32.9%) had suffered abuse (27 emotional abuse, 6 physical abuse, 3 sexual abuse, 13 emotional and physical abuse, 4 unknown type). Seven (4.3%) had suffered abuse in the last year (5 emotional, 2 physical). Abuse had lasted a median of 48 months (interquartile range 12-81). HIV status was considered as a cause of violence by 9.4% of victims. In the multivariable analysis, only abuse was independently associated with non-adherence [adjusted odds ratio (aOR) 3.92; 95% confidence interval (CI) 1.80-8.84; p = 0.0007]. Abuse (aOR 6.14; 95% CI 1.63-27.70; p = 0.001) and previous incarceration (aOR 15.08 95% CI 2.71-104.71; p = 0.003) were associated with detectable viral load. In conclusion, the prevalence of abuse is high in PLHIV, hampering adherence and virological success. Abuse screening tools should be incorporated into routine HIV care.
Filiaciones:
:
Internal Medicine, Hospital Vega Baja-FISABIO, Orihuela, Spain
Clinical Medicine Department, Universidad Miguel Hernández, Elche, Spain
:
Clinical Medicine Department, Universidad Miguel Hernández, Elche, Spain
Infectious Diseases Unit, Hospital General Universitario de Elche-FISABIO, Elche, Spain
:
Clinical Medicine Department, Universidad Miguel Hernández, Elche, Spain
Infectious Diseases Unit, Hospital General Universitario de Elda-FISABIO, Elda, Spain
:
Internal Medicine, Hospital Vega Baja-FISABIO, Orihuela, Spain
:
Clinical Medicine Department, Universidad Miguel Hernández, Elche, Spain
Infectious Diseases Unit, Hospital General Universitario de Elche-FISABIO, Elche, Spain
:
Clinical Medicine Department, Universidad Miguel Hernández, Elche, Spain
Infectious Diseases Unit, Hospital General Universitario de Elda-FISABIO, Elda, Spain
:
Farmacology Department, Hospital General Universitario de Elda-FISABIO, Elda, Spain
:
Clinical Medicine Department, Universidad Miguel Hernández, Elche, Spain
Infectious Diseases Unit, Hospital General Universitario de Elche-FISABIO, Elche, Spain
:
Farmacology Department, Hospital Vega Baja-FISABIO, Orihuela, Spain
:
Internal Medicine, Hospital Universitario San Juan de Alicante-FISABIO, Sant Joan d'Alacant, Spain
|